Biotron pioneer dies
Tuesday, 16 August, 2005
Peter Gage, an internationally recognised pioneer of the use of ion channels as a treatment for viral diseases, died on August 13 after a long illness.
A professor of physiology at Australian National University's John Curtin School of Medical Research, Gage's research formed the basis of Canberra biotech company Biotron's (ASX:BIT) Virion project, an antiviral treatment nearing commercialisation for the treatment of a range of viruses including HIV and hepatitis C.
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
Portable point-of-care test detects four common STIs in under an hour
Australian researchers have developed a portable point-of-care test that detects four common...
AusBiotech and Proto Axiom partner on investor-focused life sciences programs
AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...
